Stock CORBF GLOBAL CORD BLOOD CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Global Cord Blood Corporation

Equities

CORBF

KYG393421030

Healthcare Facilities & Services

Market Closed - OTC Markets
Other stock markets
 03:04:15 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.25 USD 0.00% Intraday chart for Global Cord Blood Corporation 0.00% +2.46%
2023 Global Cord Blood Corporation Announces Board Appointments CI
2023 Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index CI

Valuation

Fiscal Period: März 2017 2018 2019 2020 2021 2022
Capitalization 1 3,347 7,281 5,727 2,737 3,608 2,968
Enterprise Value (EV) 1 867.5 3,030 728.6 -2,733 -2,466 -3,693
P/E ratio 28.8 x 32.2 x 19.6 x 5.82 x 7.1 x 5.93 x
Yield - 0.78% - - - -
Capitalization / Revenue 4.4 x 7.77 x 5.8 x 2.24 x 3.11 x 2.39 x
EV / Revenue 1.14 x 3.23 x 0.74 x -2.24 x -2.13 x -2.97 x
EV / EBITDA 2.75 x 9.17 x 1.68 x -4.49 x -4.15 x -5.62 x
EV / FCF 3.92 x 10.2 x 1.84 x -8.95 x -6.24 x -9.75 x
FCF Yield 25.5% 9.8% 54.3% -11.2% -16% -10.3%
Price to Book 1.82 x 2.49 x 1.68 x 0.71 x 0.82 x 0.61 x
Nbr of stocks (in thousands) 73,003 113,525 121,551 121,551 121,551 121,551
Reference price 2 45.84 64.13 47.11 22.52 29.68 24.42
Announcement Date 7/25/17 7/23/18 7/23/19 7/29/20 7/29/21 8/16/22
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2017 2018 2019 2020 2021 2022
Net sales 1 760 936.8 986.8 1,221 1,160 1,243
EBITDA 1 315.3 330.5 434 608.5 594 656.8
EBIT 1 264.9 279.9 381.7 559 544.9 608.9
Operating Margin 34.85% 29.88% 38.68% 45.77% 46.99% 48.97%
Earnings before Tax (EBT) 1 166.3 303.5 356.5 578.8 610.8 627.8
Net income 1 126.2 237.1 291.1 470.7 508.2 501.1
Net margin 16.6% 25.31% 29.5% 38.54% 43.83% 40.3%
EPS 2 1.590 1.990 2.400 3.870 4.180 4.120
Free Cash Flow 1 221.2 296.8 395.4 305.3 395 378.6
FCF margin 29.1% 31.68% 40.07% 24.99% 34.06% 30.45%
FCF Conversion (EBITDA) 70.14% 89.81% 91.11% 50.17% 66.5% 57.64%
FCF Conversion (Net income) 175.27% 125.18% 135.83% 64.86% 77.71% 75.55%
Dividend per Share - 0.5019 - - - -
Announcement Date 7/25/17 7/23/18 7/23/19 7/29/20 7/29/21 8/16/22
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: March 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 2,479 4,251 4,998 5,470 6,074 6,661
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 221 297 395 305 395 379
ROE (net income / shareholders' equity) 7.24% 9.71% 9.03% 13.1% 12.5% 11%
ROA (Net income/ Total Assets) 3.35% 3.17% 3.85% 5.07% 4.5% 4.63%
Assets 1 3,762 7,474 7,564 9,276 11,288 10,824
Book Value Per Share 2 25.20 25.80 28.10 31.90 36.00 40.10
Cash Flow per Share 2 48.10 35.20 41.10 45.00 50.00 54.80
Capex 1 24.7 67.1 30.7 24.2 20.9 19.8
Capex / Sales 3.25% 7.16% 3.11% 1.98% 1.8% 1.59%
Announcement Date 7/25/17 7/23/18 7/23/19 7/29/20 7/29/21 8/16/22
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
GLOBAL CORD BLOOD CORPORATION Stock Global Cord Blood Corporation
+2.46% 167M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.62% 29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.40% 11.77B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
DAVITA INC. Stock DaVita Inc.
+27.44% 11.71B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CORBF Stock
  4. Financials Global Cord Blood Corporation